Burcon Nutrascience Corporation
BU.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 550.76% | 490.26% | 332.70% | 186.43% | 13.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 550.76% | 490.26% | 332.70% | 186.43% | 13.02% |
| Cost of Revenue | 286.68% | 693.80% | 941.32% | 1,187.41% | 1,251.26% |
| Gross Profit | -233.63% | -785.49% | -1,590.18% | -4,092.55% | -1,224.36% |
| SG&A Expenses | -11.79% | -23.35% | -26.71% | -22.26% | -15.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 70.84% | 69.21% | 42.32% | 21.48% | 16.50% |
| Operating Income | -42.96% | -48.20% | -29.38% | -15.56% | -16.71% |
| Income Before Tax | -53.10% | -77.69% | -56.86% | -30.17% | -29.70% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -47.08% | -72.98% | -56.86% | -30.17% | -29.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.08% | -72.98% | -56.86% | -30.17% | -29.70% |
| EBIT | -42.96% | -48.20% | -29.38% | -15.56% | -16.71% |
| EBITDA | -12.16% | -45.54% | -26.51% | -11.78% | -12.08% |
| EPS Basic | -5.55% | -4.84% | 10.86% | 19.83% | 9.19% |
| Normalized Basic EPS | -9.90% | -7.71% | 10.88% | 19.85% | 9.21% |
| EPS Diluted | -5.75% | -4.82% | 10.66% | 19.65% | 8.99% |
| Normalized Diluted EPS | -9.90% | -7.71% | 10.88% | 19.85% | 9.21% |
| Average Basic Shares Outstanding | 37.71% | 62.28% | 73.57% | 59.51% | 44.09% |
| Average Diluted Shares Outstanding | 37.71% | 62.28% | 73.57% | 59.51% | 44.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |